Evidence map›Paper›PMID 40078249›Full record

ArticleCureus2025

From Innocuous to Aggressive: A Case of Odontogenic Keratocyst Transforming to Unicystic Ameloblastoma.

Sharadindu M Kotrashetti, Shinju John, Vijayalakshmi Kotrashetti, Richa Mishra, Sakshi Panday

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Histopathological crossover between unicystic ameloblastoma and odontogenic keratocyst in 12-year-old: a case report with literature review.European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sharadindu M KotrashettiOral and Maxillofacial Surgery, KLE Vishwanath Katti Institute of Dental Sciences, Belagavi, IND.
Shinju JohnOral and Maxillofacial Surgery, KLE Vishwanath Katti Institute of Dental Sciences, Belagavi, IND.
Vijayalakshmi KotrashettiOral and Maxillofacial Pathology, Maratha Mandal's Nathajirao G. Halgekar Institute of Dental Sciences and Research Centre, Belagavi, IND.
Richa MishraOral and Maxillofacial Surgery, KLE Vishwanath Katti Institute of Dental Sciences, Belagavi, IND.
Sakshi PandayOral and Maxillofacial Surgery, KLE Vishwanath Katti Institute of Dental Sciences, Belagavi, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Odontogenic keratocysts are known for their aggressive and recurrent nature. Clinically and radiographically distinguishing between ameloblastoma and odontogenic keratocysts can be challenging due to their similar locations, age of affected patients, and multilocular appearance. Ameloblastomas co-occurring with odontogenic cysts or other odontogenic lesions have been documented as combined lesions. However, unique incidences of odontogenic keratocysts showing changes of unicystic ameloblastomas are scarce, especially a large aggressive lesion occurring in the mandible extending from the molar-to-molar tooth region in a young patient as presented in this case. This transformation is rare and intriguing and warrants detailed exploration and documentation. Considering the rarity of the lesion, this case highlights the importance of considering the aggressive nature of the lesion and its transformation into ameloblastoma, cautioning the surgeon to have a long-term follow-up to evaluate recurrence and emphasizing the regeneration and restoration of quality of life in young patients.

Indexed as

cone beam computed tomographycyst enucleationmandibleodontogenic keratocystunicystic ameloblastoma

Identifiers

PMID40078249
PMCPMC11897925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.